Posted by Michael Wonder on 15 May 2018
US could see lower drug prices if Europe pays more of its fair share
15 May 2018 - The idea behind the Trump plan is drug companies should raise prices overseas where governments subsidise costs in order to lower prices in the U.S.
U.S. allies' drug pricing strategies are not sustainable for long-term success, and that's adversely leading to higher prescription costs at home and abroad, FDA Commissioner Dr. Scott Gottlieb told CNBC on Tuesday.
Europeans "do underpay relative to us for branded drugs and that's in part because they do put price controls and utilisation restrictions on those drugs," Gottlieb said in a "Squawk Box" interview. "But they're overpaying relative to us on generic drugs."
